ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
SpringWorks Therapeutics raises $125m for rare oncology programmes pharmaceutical-technology
April 03, 2019US-based SpringWorks Therapeutics, which specialises on developing medicines and treatments for cancers and severe rare diseases, has raised $125m in a series B funding round led by Perceptive Advisors. -
Canadians with rare lung disease are relieved to now have publicly funded access to potentially life-extending treatment
firstwordpharma
December 02, 2018At the end of a successful Pulmonary Hypertension Awareness Month, members of the Pulmonary Hypertension Association of?Canada?(PHA Canada) and Scleroderma Canada (SC) have come together to thank provincial governments for providing the majority of Canadi
Pharma Sources Insight January 2025
